Insmed Inc (FRA:IM8N)
€ 66.5 -1 (-1.52%) Market Cap: 11.45 Bil Enterprise Value: 11.43 Bil PE Ratio: 0 PB Ratio: 308.84 GF Score: 61/100

Insmed Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2021 / 03:30PM GMT
Release Date Price: €28 (-2.78%)
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

Welcome, everyone, to the 2021 Credit Suisse Healthcare Conference. I'm Judah Frommer, senior biotech analyst here at CS. And we're thrilled to have Will Lewis, Chair and CEO from Insmed, here with us.

I'll just remind the audience, if you do have any questions you'd like to ask Will, you can certainly e-mail those over to me, [email protected].

Questions & Answers

Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

And with that, let's jump in. Will, you've outlined the framework of 4 strategic pillars for the company. So maybe to better understand the Insmed story, can you walk us through those pillars before we delve deeper into each one?

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Sure. And I have to say, to start out, we are in a fantastic position as a company. I mean I think we have centered around these 4

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot